Next Article in Journal
Giving a Hand: Synthetic Peptides Boost the Antifungal Activity of Itraconazole against Cryptococcus neoformans
Next Article in Special Issue
In Vitro Activity of Ceftolozane-Tazobactam against Escherichia coli, Klebsiella pneumoniae and Pseudomonas aeruginosa Obtained from Blood Cultures from Sentinel Public Hospitals in South Africa
Previous Article in Journal
trans-Cinnamaldehyde as a Novel Candidate to Overcome Bacterial Resistance: An Overview of In Vitro Studies
Previous Article in Special Issue
Pharmacokinetic/Pharmacodynamic Analysis of Continuous-Infusion Fosfomycin in Combination with Extended-Infusion Cefiderocol or Continuous-Infusion Ceftazidime-Avibactam in a Case Series of Difficult-to-Treat Resistant Pseudomonas aeruginosa Bloodstream Infections and/or Hospital-Acquired Pneumonia
 
 
Article

Article Versions Notes

Antibiotics 2023, 12(2), 255; https://doi.org/10.3390/antibiotics12020255
Action Date Notes Link
article xml file uploaded 27 January 2023 10:13 CET Original file -
article xml uploaded. 27 January 2023 10:13 CET Update https://www.mdpi.com/2079-6382/12/2/255/xml
article pdf uploaded. 27 January 2023 10:14 CET Version of Record https://www.mdpi.com/2079-6382/12/2/255/pdf
article supplementary file uploaded. 27 January 2023 10:14 CET - https://www.mdpi.com/2079-6382/12/2/255#supplementary
article html file updated 27 January 2023 10:15 CET Original file -
article html file updated 1 March 2023 11:18 CET Update -
article html file updated 8 March 2023 02:40 CET Update https://www.mdpi.com/2079-6382/12/2/255/html
Back to TopTop